Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs

Abstract

Background The amount of surfactant deposited in the lungs and its overall pulmonary distribution determine the therapeutic outcome of surfactant replacement therapy. Most of the currently available methods to determine the intrapulmonary distribution of surfactant are time-consuming and require surfactant labelling. Our aim was to assess the potential of Mass Spectrometry Imaging (MSI) as a label-free technique to qualitatively and quantitatively evaluate the distribution of surfactant to the premature lamb. Methods Twelve preterm lambs (gestational age 126-127d, term ~150d) were allocated in two experimental groups. Seven lambs were treated with an intratracheal bolus of the synthetic surfactant CHF5633 (200 mg/kg) and 5 lambs were managed with mechanical ventilation for 120 min, as controls. The right lung lobes of all lambs were gradually frozen while inflated to 20 cmH 2 O pressure for lung cryo-sections for MSI analysis. The intensity signals of SP-C analog and SP-B analog, the two synthetic peptides contained in the CHF5633 surfactant, were used to locate, map and quantify the intrapulmonary exogenous surfactant. Results Surfactant treatment was associated with a significant improvement of the mean arterial oxygenation and lung compliance ( p < 0.05). Nevertheless, the physiological response to surfactant treatment was not uniform across all animals. SP-C analog and SP-B analog were successfully imaged and quantified by means of MSI in the peripheral lungs of all surfactant-treated animals. The intensity of the signal was remarkably low in untreated lambs, corresponding to background noise. The signal intensity of SP-B analog in each surfactant-treated animal, which represents the surfactant distributed to the peripheral right lung, correlated well with the physiologic response as assessed by the area under the curves of the individual arterial partial oxygen pressure and dynamic lung compliance curves of the lambs. Conclusions Applying MSI, we were able to detect, locate and quantify the amount of exogenous surfactant distributed to the lower right lung of surfactant-treated lambs. The distribution pattern of SP-B analog correlated well with the pulmonary physiological outcomes of the animals. MSI is a valuable label-free technique which is able to simultaneously evaluate qualitative and quantitative drug distribution in the lung. Electronic supplementary material The online version of this article (10.1186/s12931-019-1144-5) contains supplementary material, which is available to authorized users.

Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging

“…MSI is a mass spectrometry technique that provides label-free visualization of the analytes of interest. We have previously utilized MSI to investigate the pulmonary distribution of natural (Poractant alfa) and synthetic (CHF5633, Chiesi Farmaceutici, Parma, Italy) surfactants in surfactant-depleted rabbits and in premature lambs [54,55]. In these studies, we visualized the pulmonary distribution of exogenous surfactants by following the unique spectral signals of the porcine SP-C and synthetic SP-C analogue ions.…”

Surfactant lung delivery with LISA and InSurE in adult rabbits with respiratory distress

“…All data analyses were performed in R (https://www.R-project.org). Data normalization and preprocessing were the same as described by Zecchi et al 32 Briefly, all analyses were performed on the log-transformed MSI intensity to compensate for the expected heteroscedasticity of this type of data. An additional step of batch correction was implemented by setting to zero the average intensity measured on the background pixels.…”

Quantification of Irinotecan in Single Spheroids Using Internal Standards by MALDI Mass Spectrometry Imaging

“…1 It was initially applied to mass spectrometry imaging (MSI) by Caprioli et al to study the localization of peptides and proteins in different rat tissue sections. 2 Since then, MALDI-MSI has been widely used to study the distribution of various molecules including both endogenous 3 and exogenous 4 metabolites, lipids, 5 and drugs. 6 The ability of localize parent drugs and their metabolites simultaneously, combined with quantification strategies, has made MALDI-MSI an emerging tool in drug development and pharmaceutical research.…”